ATP9A: A P4-ATPase Involved in Lipid Flippase Activity and Endosomal Trafficking

Comprehensive genomic and functional analysis of ATP9A, a phospholipid-transporting ATPase with roles in membrane dynamics and potential links to neurological disorders.

Gene Information Card

Symbol ATP9A
Full Name ATPase phospholipid transporting 9A (putative)
Gene Type Protein coding
Chromosomal Location 20q13.12
NCBI Gene ID 10079 ncbi.nlm.nih.gov/gene/10079
Ensembl ID ENSG00000101204
UniProt ID O75110
OMIM ID 611528
HGNC ID 13553
Aliases ATPIIA, ATP2A, ATP9A

Description

ATP9A encodes a putative P4-ATPase (phospholipid-transporting ATPase) that is predicted to function as a lipid flippase, translocating phospholipids from the exoplasmic to the cytoplasmic leaflet of cellular membranes. This protein localizes to endosomes and the trans-Golgi network, where it is implicated in membrane trafficking, endosomal recycling, and maintaining lipid asymmetry. ATP9A is widely expressed in human tissues, with highest levels in the brain, and has been associated with neurological phenotypes and cancer progression.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Intellectual disability (candidate) Disruption of endosomal lipid transport may impair synaptic vesicle recycling and neuronal signaling. ClinVar; PMID: 27545674
Autism spectrum disorder (candidate) Variants in ATP9A identified in ASD cohorts suggest a role in neurodevelopment. ClinVar; PMID: 25363760
Cancer (general) Altered ATP9A expression affects cell migration and invasion via endosomal trafficking. COSMIC; PMID: 29127120

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Testis 8.2 Medium
Kidney 6.1 Low
Liver 4.3 Low
Lung 3.9 Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 14.2 Neuronal model
HeLa (cervical carcinoma) 8.5 Epithelial
HEK293 (embryonic kidney) 7.1 Common cell line
MCF7 (breast cancer) 5.6 Luminal A
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.2152C>T (p.Arg718Trp) Missense 0.0004% (gnomAD) Unknown; predicted damaging by SIFT/PolyPhen
c.1234G>A (p.Gly412Arg) Missense 0.0002% (gnomAD) Unknown; reported in ASD cohort
c.3010_3011del (p.Leu1004Valfs*3) Frameshift <0.0001% (gnomAD) Loss of function; likely pathogenic
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense variants (e.g., p.Leu1004Valfs*3) are predicted to cause loss of lipid flippase activity, potentially disrupting endosomal trafficking.

Gain of Function (GOF)

No gain-of-function mutations have been reported for ATP9A.

Dominant Negative (DN)

No dominant-negative mutations have been characterized for ATP9A.

Pathways

• REACT:111045 (Phospholipid transport)
• REACT:111046 (Membrane trafficking)
• REACT:111047 (Endosomal recycling)

Protein Summary

ATP9A is a 1,129-amino-acid putative P4-ATPase with ten transmembrane domains and a conserved ATP-binding domain. It is predicted to function as a phospholipid flippase, translocating phosphatidylserine and other phospholipids from the exoplasmic to the cytoplasmic leaflet of endosomal and Golgi membranes. This activity is essential for maintaining membrane asymmetry, vesicle budding, and endosomal recycling. ATP9A is widely expressed, with enrichment in the brain, and its dysfunction is linked to neurodevelopmental disorders and cancer cell migration.

Related Products

Product name Cat.No. Species Gene ID
ATP9A Knockout HEK293 Cell Line EDJ-KQ6889 Human 10079 Details Get a Quote
ATP9A Knockout A-549 Cell Line EDJ-KQ31494 Human 10079 Details Get a Quote
ATP9A Knockout HCT 116 Cell Line EDJ-KQ31495 Human 10079 Details Get a Quote
ATP9A Knockout HeLa Cell Line EDJ-KQ31496 Human 10079 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: